RIKEN Center for Sustainable Resource Science Drug Discovery Platforms Cooperation Division
Division Director: Minoru Yoshida (D.Agr.)
Research Summary
The increased availability of genomic sequence information has already allowed the identification of numerous novel drug targets. The next challenge lies in developing new technology and assays, to further expand and exploit available genomic information obtained from basic research, and begin translational programs that will lead towards actual application and patient treatment. Academic drug discovery has become a world-wide movement at universities and research institutions, in response to which the RIKEN launched the Drug Discovery and Medical Technology Platform (DMP). Capitalizing on RIKEN’s excellent track record in basic science and technology, including a vast library of bioactive natural products and state of the art equipment for high throughput screening, Our division aims at making innovative contributions to the academic drug discovery effort.
Main Research Fields
- Biology
Related Research Fields
- Chemistry
Keywords
- Chemical Biology
- Epigenetics
- Mode of Action
- Transcriptional Regulation
- Chemical Screening for Drug Discovery
Related Links
Lab Members
Principal investigator
- Minoru Yoshida
- Division Director
Contact Information
2-1 Hirosawa, Wako, Saitama 351-0198, Japan
Tel: +81-(0)48-467-9516
Fax: +81-(0)48-462-4676
Email: yoshidam [at] riken.jp
Organization
- Drug Discovery Chemical Bank Unit
- Hiroyuki Osada (D.Agr.)
- Drug Discovery Seed Compounds Exploratory Unit
- Minoru Yoshida (D.Agr.)
- Drug Discovery Chemistry Platform Unit
- Hiroo Koyama (Ph.D.)